Iranian COVID-19 vaccine starts clinical trial

TEHRAN, Mar. 15 (MNA) – Phases two and three of clinical trials of the first Iranian corona vaccine, produced and manufactured by the domestic researchers at Execution of Imam Khomeini Order (EIKO), entitled COVO Iran Barakat” kicked off on Mon.

The Director of Clinical Trial Center of Tehran University of Medical Sciences (TUMS) Dr. Hamed Hosseini broke the news on Monday and said that the next phase of the human test of the Iranian COVID-19 vaccine will start today and the third phase will be implemented in tandem with this phase.

Licensed by Iran Food and Drug Administration (FDI) and the National Ethics Committee, the feasibility study of the 2nd and 3rd phases of the human test of Iranian vaccine dubbed “COVO Iran Barakat” will be carried out together, he added.

It should be noted that the first human injection of the first phase of clinical trials of the COVID-19 vaccine was carried out on Tue. ِDec. 29 in the presence of Iranian Minister of Health Namaki and Vice-President for Science and Technology Sorena Sattari.


News Code 171113


Your Comment

You are replying to: .
  • captcha